Transcriptomic Profiling of Cumulus Cells From CAPA-IVM

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-38
SponsorMỹ Đức Hospital

About this trial

Capacitation in vitro maturation (CAPA-IVM) has improved oocyte maturation and resulted in live births. Because cumulus cells (CCs) communicate bidirectionally with the oocyte, their transcriptomic profile may serve as a non-invasive biomarker of oocyte and embryo competence. This prospective pilot study will analyze CCs gene expression after CAPA-IVM using RNA sequencing and pathway analysis, and correlate findings with embryological outcomes including fertilization, day-3 cleavage, and blastocyst formation. Results are expected to provide insights into the molecular basis of oocyte competence and support development of non-invasive embryo selection strategies.

Eligibility criteria

Qualifiers

Women 18-38 years

BMI =< 32kg/m2

Diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam 2003 criteria, meet at least 2 of the following 3 features: (1) Oligo-ovulation or anovulation. (2) Clinical and/or biochemical signs of hyperandrogenism (3) Polycystic ovarian morphology on ultrasound.

Indicated for CAPA-IVM treatment.

Disqualifiers

Retrieved sperm from surgical procedures

Previous IVF cycle with total immature oocytes

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

10 Participants
are grouped into 1 trial group

Sponsors and collaborators

Mỹ Đức Hospital

Lead sponsor

Vrije Universiteit Brussel

Collaborator